New Cousteau-Linked...
AngioDynamics Inc. (ANGO: NASDAQ)
$11.90 -0.14 | -1.16%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| May 2011 | May 2010 | May 2009 | May 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 45.98M | 58.76M | 27.91M | 32.04M |
| Receivables | 27.14M | 29.84M | 27.18M | 26.64M |
| Inventories | 28.13M | 29.22M | 36.93M | 22.90M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 194.30M | 171.36M | 148.60M | 141.88M |
| Property, Plant & Equipment, Gross | 43.85M | 40.90M | 36.62M | 32.91M |
| Accumulated Depreciation & Depletion | 20.05M | 16.70M | 14.43M | 11.75M |
| Property, Plant & Equipment, Net | 23.80M | 24.19M | 22.18M | 21.16M |
| Intangibles | 48.04M | 58.35M | 67.77M | 71.31M |
| Other Non-Current Assets | 3.49M | 5.52M | 3.92M | 4.82M |
| Total Non-Current Assets | 243.12M | 252.56M | 260.10M | 266.86M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 437.42M | 423.92M | 408.70M | 408.75M |
| Accounts Payable | 11.39M | 12.04M | 13.15M | 9.08M |
| Short Term Debt | 275.00K | 260.00K | 265.00K | 10.04M |
| Other Current Liabilities | 0.00 | 0.00 | 5.23M | 12.69M |
| Total Current Liabilities | 25.51M | 26.03M | 29.70M | 41.33M |
| Long Term Debt | 6.28M | 6.55M | 6.81M | 7.08M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 4.62M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 6.28M | 6.55M | 6.81M | 11.70M |
| Total Liabilities | 31.78M | 32.58M | 36.51M | 53.03M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 405.64M | 391.35M | 372.19M | 355.71M |
| Common Par | 250.00K | 247.00K | 245.00K | 243.00K |
| Additional Paid In Capital | 371.39M | 365.34M | 358.01M | 350.60M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 35.27M | 27.15M | 14.84M | 4.91M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -1.27M | -1.39M | -905.00K | -36.00K |
| Total Capitalization | 411.91M | 397.90M | 379.00M | 362.79M |
| Total Equity | 405.64M | 391.35M | 372.19M | 355.71M |
| Total Liabilities & Stock Equity | 437.42M | 423.92M | 408.70M | 408.75M |
| Total Common Shares Outstanding | 24.99M | 24.75M | 24.43M | 24.27M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 24.87M | 24.58M | 24.36M | 24.08M |
| Diluted Weighted Shares Outstanding | 25.13M | 24.79M | 24.51M | 24.35M |
| Number of Employees | 722 | 681 | 715 | 566 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ANGO
- Portfolio NameUser Type
- UserMedical devices M&A
- ContributorEarnings Short Squeeze Play...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserLast Day of the JPMorgan He...
- UserDrewski2 Portfolio 1
- Userwafessler Portfolio 1
- UserRPavlovic Portfolio 1
- UserGluck Portfolio 1
- Userchappervester Portfolio 1
Latest ANGO Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript 04.04.12 | 08:04 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 03.09.12 | 04:03 am
- AngioDynamics Inc. Presents At The 30th Annual JPMorgan Chase Healthcare Conference, Jan-12-2012 10:30 AM 01.12.12 | 08:01 pm
- AngioDynamics Inc. Stock Upgraded (ANGO) 01.09.12 | 05:01 am
- AngioDynamics' CEO Discusses Q2 2012 Results - Earnings Call Transcript 01.05.12 | 10:01 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 11.29.11 | 06:11 am
- AngioDynamics Inc. Stock Upgraded (ANGO) 10.26.11 | 07:10 am
- AngioDynamics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 10.06.11 | 09:10 pm
- 5 Earnings Stocks to Squeeze the Bears 10.04.11 | 01:10 pm
Press Releases for ANGO
- NanoKnife® System Clinical Experience Featured At Society Of Surgical Oncology Conference - Business Wire 04.02.12 | 06:04 am
- Five Oral Presentations On Clinical Experience With NanoKnife® System Featured At Society Of Interventional Radiology Conference - Business Wire 03.29.12 | 06:03 am
- AngioDynamics Establishes Strategic Relationship With Microsulis Medical Ltd. - Business Wire 03.26.12 | 06:03 am
- Scott Solano To Depart AngioDynamics - Business Wire 09.22.11 | 04:09 pm
- AngioDynamics Names Joseph M. DeVivo President And CEO - Business Wire 08.16.11 | 07:08 am
- AngioDynamics Reports Fiscal 2011 Fourth Quarter And Full Year Financial Results - Business Wire 07.14.11 | 04:07 pm
- AngioDynamics To Report Fiscal 2011 Fourth Quarter And Full Year Financial Results And Hold Conference Call On July 14, 2011 - Business Wire 07.05.11 | 06:07 am
- AngioDynamics Reports Preliminary Fiscal 2011 Fourth Quarter Financial Results And Corporate Developments - Business Wire 06.13.11 | 04:06 pm
- AngioDynamics Launches VenaCure® 1470nm Laser For Treatment Of Varicose Veins - Business Wire 05.31.11 | 06:05 am
- AngioDynamics Expands VenaCure EVLT® System For Varicose Veins With Longer 90 Cm Kit - Business Wire 05.26.11 | 06:05 am
Partner Headlines for ANGO
- The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases - Zacks 05.24.12 | 09:05 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- 6 Insider Stock Picks Rated Buy By Canaccord Genuity - Seeking Alpha 02.10.12 | 05:02 pm
- AngioDynamics Cuts View on Recall - Analyst Blog - Zacks 01.27.12 | 07:01 pm
- AngioDynamics Beats, Tweaks View - Analyst Blog - Zacks 01.06.12 | 09:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BSD Promotes Hyperthermia Tech - Analyst Blog - Zacks 10.31.11 | 07:10 pm
- Bard's 3Q Mixed, Buying Medivance - Analyst Blog - Zacks 10.26.11 | 09:10 am
- AngioDynamics Trades Lower on Q1 Earnings Results - Benzinga 10.06.11 | 04:10 pm
- Company News for June 16, 2011 - Corporate Summary - Zacks 06.16.11 | 10:06 am





